Clinical trial
Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
NCT00090727 · Novacea, Industry · Unknown status
Key facts
| NCT number | NCT00090727 |
|---|---|
| Title | Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma |
| Official title | A Phase 1, Open-Label, Dose-Escalation Study of AQ4N Administered Intravenously in Patients With Advanced Malignancies |
| Lead sponsor | Novacea, Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Solid Malignancies, Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | AQ4N |
| Enrollment | 45 |
| Start date | Aug 1, 2004 |
| First posted | Sep 6, 2004 |
| Last update posted | Nov 2, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: